Trial Profile
Single-Dose, Two-Period, Open Label, Dose Determination, Randomized, Cross-Over Study of CTAP201 Injection and Doxercalciferol (Hectorol) Injection in Subjects With Stage 5 CKD and SHPT on Hemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs CTAP 201 (Primary) ; Doxercalciferol
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions; Pharmacokinetics
- 08 Sep 2015 New trial record